208 related articles for article (PubMed ID: 37149065)
1. Yinchen decoction protects against cholic acid diet-induced cholestatic liver injury in mice through liver and ileal FXR signaling.
Song G; Zou B; Zhao J; Weng F; Li Y; Xu X; Zhang S; Yan D; Jin J; Sun X; Liu C; Qiu F
J Ethnopharmacol; 2023 Sep; 313():116560. PubMed ID: 37149065
[TBL] [Abstract][Full Text] [Related]
2. Artemisia capillaris Thunb. Polysaccharide alleviates cholestatic liver injury through gut microbiota modulation and Nrf2 signaling pathway activation in mice.
Cai J; Zhu Z; Li Y; Li Q; Tian T; Meng Q; Wang T; Ma Y; Wu J
J Ethnopharmacol; 2024 Jun; 327():118009. PubMed ID: 38447617
[TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway.
Song G; Weng F; Zou B; Zhao J; Jin J; Yan D; Huang K; Sun X; Liu C; Hu Y; Li Y; Qiu F
Clin Sci (Lond); 2023 Apr; 137(7):561-577. PubMed ID: 36795945
[TBL] [Abstract][Full Text] [Related]
4. Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters.
Xue H; Fang S; Zheng M; Wu J; Li H; Zhang M; Li Y; Wang T; Shi R; Ma Y
J Ethnopharmacol; 2021 Apr; 269():113706. PubMed ID: 33346024
[TBL] [Abstract][Full Text] [Related]
5. Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis.
Liu J; Liu J; Meng C; Huang C; Liu F; Xia C
Phytomedicine; 2022 Jul; 102():154173. PubMed ID: 35605478
[TBL] [Abstract][Full Text] [Related]
6. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
[TBL] [Abstract][Full Text] [Related]
7. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.
Wang MQ; Zhang KH; Liu FL; Zhou R; Zeng Y; Chen AL; Yu Y; Xia Q; Zhu CC; Lin CZ
Phytomedicine; 2024 Jan; 122():155124. PubMed ID: 38014837
[TBL] [Abstract][Full Text] [Related]
8. Identifying hepatoprotective mechanism and effective components of Yinchenzhufu decoction in chronic cholestatic liver injury using a comprehensive strategy based on metabolomics, molecular biology, pharmacokinetics, and cytology.
Li Y; Peng X; Wang G; Zan B; Wang Y; Zou J; Tian T; Meng Q; Shi R; Wang T; Wu J; Ma Y
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117060. PubMed ID: 37598769
[TBL] [Abstract][Full Text] [Related]
9. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
[TBL] [Abstract][Full Text] [Related]
10. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
[TBL] [Abstract][Full Text] [Related]
11. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype.
Abu-Hayyeh S; Papacleovoulou G; Lövgren-Sandblom A; Tahir M; Oduwole O; Jamaludin NA; Ravat S; Nikolova V; Chambers J; Selden C; Rees M; Marschall HU; Parker MG; Williamson C
Hepatology; 2013 Feb; 57(2):716-26. PubMed ID: 22961653
[TBL] [Abstract][Full Text] [Related]
13. Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.
Kulkarni SR; Soroka CJ; Hagey LR; Boyer JL
Hepatology; 2016 Dec; 64(6):2151-2164. PubMed ID: 27639250
[TBL] [Abstract][Full Text] [Related]
14. Targeting FXR in Cholestasis.
Keitel V; Dröge C; Häussinger D
Handb Exp Pharmacol; 2019; 256():299-324. PubMed ID: 31201556
[TBL] [Abstract][Full Text] [Related]
15. Farnesoid X receptor contributes to oleanolic acid-induced cholestatic liver injury in mice.
Feng H; Hu Y; Zhou S; Lu Y
J Appl Toxicol; 2022 Aug; 42(8):1323-1336. PubMed ID: 35128688
[TBL] [Abstract][Full Text] [Related]
16. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
[TBL] [Abstract][Full Text] [Related]
17. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
18. Yinchenzhufu decoction protects against alpha-naphthylisothiocyanate-induced acute cholestatic liver injury in mice by ameliorating disordered bile acid homeostasis and inhibiting inflammatory responses.
Wang GF; Li YY; Shi R; Wang TM; Li YF; Li WK; Zheng M; Fan FB; Zou J; Zan B; Wu JS; Ma YM
J Ethnopharmacol; 2020 May; 254():112672. PubMed ID: 32084553
[TBL] [Abstract][Full Text] [Related]
19. Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats.
Wang M; Liu F; Yao Y; Zhang Q; Lu Z; Zhang R; Liu C; Lin C; Zhu C
J Ethnopharmacol; 2021 Apr; 270():113816. PubMed ID: 33444723
[TBL] [Abstract][Full Text] [Related]
20. The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis.
Santamaría E; Rodríguez-Ortigosa CM; Uriarte I; Latasa MU; Urtasun R; Alvarez-Sola G; Bárcena-Varela M; Colyn L; Arcelus S; Jiménez M; Deutschmann K; Peleteiro-Vigil A; Gómez-Cambronero J; Milkiewicz M; Milkiewicz P; Sangro B; Keitel V; Monte MJ; Marin JJG; Fernández-Barrena MG; Ávila MA; Berasain C
Hepatology; 2019 Apr; 69(4):1632-1647. PubMed ID: 30411380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
